Leuthold Group LLC Takes Position in Sanofi $SNY

Leuthold Group LLC purchased a new position in shares of Sanofi (NASDAQ:SNY) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 93,850 shares of the company’s stock, valued at approximately $4,548,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of SNY. Flagship Harbor Advisors LLC acquired a new position in shares of Sanofi during the 4th quarter valued at $25,000. Measured Wealth Private Client Group LLC acquired a new position in shares of Sanofi during the 3rd quarter valued at $29,000. Palisade Asset Management LLC acquired a new position in shares of Sanofi during the 3rd quarter valued at $30,000. First Horizon Corp acquired a new position in shares of Sanofi during the 3rd quarter valued at $33,000. Finally, Sittner & Nelson LLC acquired a new position in shares of Sanofi during the 3rd quarter valued at $47,000. Institutional investors and hedge funds own 14.03% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on SNY shares. Morgan Stanley set a $52.00 price target on shares of Sanofi in a research note on Friday, May 1st. Argus upgraded shares of Sanofi to a “strong-buy” rating in a research note on Monday, April 27th. Weiss Ratings upgraded shares of Sanofi from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday. BNP Paribas Exane lowered shares of Sanofi from an “outperform” rating to a “neutral” rating and set a $50.00 price target for the company. in a research note on Monday, April 20th. Finally, Wall Street Zen lowered shares of Sanofi from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 21st. Two research analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and ten have given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $51.00.

Sanofi Trading Down 0.4%

Shares of Sanofi stock opened at $42.69 on Friday. Sanofi has a 12-month low of $42.33 and a 12-month high of $53.36. The company has a market cap of $104.12 billion, a price-to-earnings ratio of 11.92, a PEG ratio of 1.05 and a beta of 0.35. The company has a current ratio of 1.01, a quick ratio of 0.22 and a debt-to-equity ratio of 0.17. The company’s 50-day moving average price is $45.60 and its 200-day moving average price is $47.46.

Sanofi Increases Dividend

The company also recently declared an annual dividend, which will be paid on Wednesday, June 3rd. Stockholders of record on Monday, May 4th will be issued a $2.4225 dividend. The ex-dividend date of this dividend is Monday, May 4th. This is a positive change from Sanofi’s previous annual dividend of $2.04. This represents a dividend yield of 559.0%. Sanofi’s payout ratio is currently 49.44%.

About Sanofi

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company headquartered in France that researches, develops, manufactures and markets prescription medicines, vaccines and consumer healthcare products. The company operates across multiple therapeutic areas, including immunology, rare diseases, oncology, cardiovascular and metabolic diseases, and vaccines through its Sanofi Pasteur division. Sanofi sells products to hospitals, clinics, governments and retail pharmacies, with a broad global footprint and significant presence in Europe, North America and emerging markets.

Key commercial offerings include specialty biologics and established small-molecule medicines.